Indonesia Syringe Market Size, Share, Opportunities, And Trends By Type (Insulin Syringe, Conventional Syringe), By Material (Glass, Plastic, Stainless Steel), And By Syringe Size (Smaller Volume Syringe, Larger Volume Syringe) - Forecasts From 2025 To 2030

The Indonesia Syringe Market is expected to grow at a rate of 75.67% CAGR, reaching a market size of US$290.446 million in 2030 from US$220.495 million in 2025.

A syringe is a glass or plastic tube containing a needle on one side. It is used to deliver the drug to the veins of the body or for taking small samples of blood for medical tests and procedures. A syringe is among the most important types of medical devices, which helps medical professionals. It has multiple benefits, like elimination of dose errors, and offers easy application and administration of medicines.

Indonesia is benefiting from greater purchasing power and improved exposure to healthcare facilities as the country's economic situation improves. The government has substantially enhanced expenditures on health care and programs supported by medicine for Indonesia's poor households. The lifestyle and dietary habits of Indonesians are changing as a result of the country's improving economic situation. This aggravates lifestyle-related health conditions like high blood pressure and hypertension. As a result, the demand for medicines and the medical equipment needed to administer them, such as syringes, has surged in Indonesia in recent years, supporting the country's syringe industry.

Hence, the growing healthcare sector in Indonesia is witnessing rapid industry development through continued efforts from governments and private organizations, leading to the market expansion of Indonesian syringes. The International Trade Administration in its report has projected the nation’s growth at about US$3,355 million, with about US$2,331 million of local healthcare production in 2021. The local production of healthcare increased to US$2,5641 million in 2022, which further rose to about US$2,808 million in 2023. This data by the International Trade Administration shows the growing healthcare sector in Indonesia which is leading the market growth of its associated industries including the syringe market. 

What are Indonesia’s syringe market drivers?

• The Indonesian syringe market is driven by the rising patient population affected by several diseases in the country.

In Indonesia, there are many cases of unusual diseases and fatal ailments. According to data from the World Health Organization (WHO), there were around 11.66 million active cases affected by kidney diseases while there were more than 10 million active diabetes patients in Indonesia in 2021. The data also stated that there were 260K patients suffering from cardiac ailments and around 400K people were suffering from different types of cancers and tuberculosis respectively in 2021. As such, the rising prevalence of several diseases and the increasing number of patients suffering from such ailments has resulted in increased demand for medical equipment for treatment, including syringes, defibrillators, and surgical tables. As such, the growing patient population in the country has favourably impacted the Indonesian syringe market.

• The extensive healthcare industry and the rising number of hospitals in the country are expected to help the Indonesian syringe market.

The number of hospitals in the country has grown and is anticipated to grow even more throughout the projected period as a result of the need to expand the capacity of healthcare facilities, as well as the significant growth in healthcare spending and optimistic economic outlook following the COVID-19 pandemic. The Indonesian government announced investments as part of the law for medical device suppliers, hospitals, pharmaceutical wholesalers, and pharmaceutical manufacturers. The Indonesian syringe market, thus, has benefitted tremendously from the extension of the healthcare industry as increased healthcare infrastructure will allow more patients to have their treatment causing the increase in demand for syringes for medical procedures.

What are Indonesia's syringe market restraints?

• The limitation of the healthcare sector to the major chunk of Indonesian is acting as a restraint for market expansion

As a substitute for the medical and healthcare services provided in hospitals, Indonesians believe in and employ a variety of traditional medical treatments and medications. Even though a large number of people are eligible for the program, access to modern healthcare is still limited for a variety of reasons, such as a lack of hospitals and clinics, a lack of knowledge, and lengthy and complicated bureaucracies for those who receive government-sponsored healthcare services. As a result, this hinders the expansion of the Indonesian syringe market.

Which segment based on syringe type will have the largest share?

The Indonesian syringe market is segmented into Insulin syringes and Conventional syringes based on the type of syringe. During the forecast period, The market for insulin syringes will grow significantly and will hold larger share in the projected period as the number of people suffering from diabetes is expected to grow in the coming years. Several factors are propelling the demand for insulin syringes. Indonesian population is facing several health issues because of lifestyle change, urbanization, and an aging population. The diagnoses for both types of diabetes have been growing enormously, ranging among the top countries in the world concerning this condition, affecting millions. Trends related to the rise of obesity, unhealthy diets, and a sedentary lifestyle contribute to the increase of diabetes in the country. Additionally, the medical infrastructure of the country is growing, and with more people becoming aware of the disease, the demand for insulin syringes will grow in the coming years.  

Recent Developments in the Indonesia syringe market:

• In September 2024: BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak™ Glass Prefillable Syringe platform to serve the growing market for biologic therapies. The BD Neopak™ Glass Prefillable Syringe platform will address the needs for biological drugs for more than 24 indications including including Crohn's disease, atopic dermatitis, cardiovascular disease and various rare diseases. The BD Neopak™ XtraFlow™ Glass Prefillable features an 8-millimeter needle length thinner wall cannula to optimize subcutaneous delivery of higher viscosity drug profiles by reducing the injection force and time required for a fixed solution viscosity.
• In October 2024: SK Bioscience, a global innovative vaccine and biotech company, has received approval for its quadrivalent cell-cultured influenza vaccine, SKYCellflu, from Indonesia's Food and Drug Agency (BPOM).  This is a significant milestone as for the first time, a domestically developed influenza vaccine has been licensed in Indonesia.

The Indonesia syringe market is analyzed into the following segments:

• By Type
  • Insulin Syringe
  • Conventional Syringe
• By Material
  • Glass
  • Plastic
  • Stainless Steel
• By Syringe Size
  • Smaller Volume Syringe
  • Larger Volume Syringe

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View 

5. INDONESIA SYRINGE MARKET BY TYPE

5.1. Introduction

5.2. Insulin Syringe

5.3. Conventional Syringe

5.3.1. Eccentric Tip Syringe

5.3.2. Catheter Tip Syringe

5.3.3. Leur Lock Syringe

6. INDONESIA SYRINGE MARKET BY MATERIAL

6.1. Introduction

6.2. Glass

6.3. Plastic

6.4. Stainless Steel

7. INDONESIA SYRINGE MARKET BY SYRINGE SIZE

7.1. Introduction

7.2. Smaller Volume Syringe

7.3. Larger Volume Syringe

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. PT. Nipro Indonesia Jaya (NIPRO)

9.2. B Braun SE

9.3. PT Oneject Indonesia (TDC Indonesia)

9.4. PT. Becton Dickinson Indonesia

9.5. ICU Medical Inc.

9.6. PT TOP POINT MEDICA (TOPPOINT)

9.7. Terumo Indonesia

9.8. ILS Innovative Labor Systems

9.9. Space Age Plastic Industries

PT. Nipro Indonesia Jaya (NIPRO)

B Braun SE

PT Oneject Indonesia (TDC Indonesia)

PT. Becton Dickinson Indonesia

ICU Medical Inc.

PT TOP POINT MEDICA (TOPPOINT)

Terumo Indonesia

ILS Innovative Labor Systems

Space Age Plastic Industries